Canagliflozin is an antidiabetic drug used to manage blood sugar levels in type 2 diabetes. It works by inhibiting the sodium-glucose transport protein 2 (SGLT2), promoting glucose excretion via urine. It is grouped under the following drug class(es): SGLT2 inhibitors. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Invokana, Sulisent and Canagliflozin anhydrous. Its PubChem CID is 24812758.
Canagliflozin
| CAS No | 842133-18-0 |
|---|---|
| Molecular Formula | C24H25FO5S |
| Molecular Weight | 444.5 g/mol |
| Synonyms | (2S,3R,4R,5S,6R)-2-{3-[5-(4-fluorophenyl)thiophen-2-ylmethyl]-4-methylphenyl}-6-(hydroxymethyl)oxane-3,4,5-triol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Canagliflozin is an antidiabetic drug used to manage blood sugar levels in type 2 diabetes. It works by inhibiting the sodium-glucose transport protein 2 (SGLT2), promoting glucose excretion via urine.
The listed CAS number is 842133-18-0.
The listed molecular formula is C24H25FO5S.
The listed molecular weight is 444.5 g/mol.
(2S,3R,4R,5S,6R)-2-{3-[5-(4-fluorophenyl)thiophen-2-ylmethyl]-4-methylphenyl}-6-(hydroxymethyl)oxane-3,4,5-triol.
The source lists Invokana, Sulisent and Canagliflozin anhydrous.